146 related articles for article (PubMed ID: 2783373)
1. Deoxycoformycin-induced immunosuppression in patients with hairy cell leukemia.
Urba WJ; Baseler MW; Kopp WC; Steis RG; Clark JW; Smith JW; Coggin DL; Longo DL
Blood; 1989 Jan; 73(1):38-46. PubMed ID: 2783373
[TBL] [Abstract][Full Text] [Related]
2. Immunohistological assessment of bone marrow biopsies from patients with hairy cell leukemia: changes following treatment with alpha-2-interferon and deoxycoformycin.
Thaler J; Denz H; Dietze O; Gastl G; Ho AD; Gattringer C; Greil R; Lechleitner M; Huber C; Huber H
Leuk Res; 1989; 13(5):377-83. PubMed ID: 2787447
[TBL] [Abstract][Full Text] [Related]
3. Response to pentostatin in hairy-cell leukemia refractory to interferon-alpha. The European Organization for Research and Treatment of Cancer Leukemia Cooperative Group.
Ho AD; Thaler J; Mandelli F; Lauria F; Zittoun R; Willemze R; McVie G; Marmont AM; Prümmer O; Stryckmans P
J Clin Oncol; 1989 Oct; 7(10):1533-8. PubMed ID: 2789273
[TBL] [Abstract][Full Text] [Related]
4. Response to 2'-deoxycoformycin after failure of interferon-alpha in nonsplenectomized patients with hairy cell leukemia.
Foon KA; Nakano GM; Koller CA; Longo DL; Steis RG
Blood; 1986 Jul; 68(1):297-300. PubMed ID: 3487358
[TBL] [Abstract][Full Text] [Related]
5. Response duration and recovery of CD4+ lymphocytes following deoxycoformycin in interferon-alpha-resistant hairy cell leukemia: 7-year follow-up.
Seymour JF; Talpaz M; Kurzrock R
Leukemia; 1997 Jan; 11(1):42-7. PubMed ID: 9001417
[TBL] [Abstract][Full Text] [Related]
6. The treatment of hairy cell leukemia (HCL) with pentostatin (2'-deoxycoformycin, dCF).
Spiers AS; Parekh SJ
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():173-5. PubMed ID: 2653498
[No Abstract] [Full Text] [Related]
7. Immunosuppressive effects of pentostatin.
Kraut EH; Neff JC; Bouroncle BA; Gochnour D; Grever MR
J Clin Oncol; 1990 May; 8(5):848-55. PubMed ID: 2332771
[TBL] [Abstract][Full Text] [Related]
8. Rapid response to 2'-deoxycoformycin in advanced hairy cell leukemia after failure of interferons alpha and gamma.
Lembersky BC; Ratain MJ; Westbrook C; Golomb HM
Am J Hematol; 1988 Jan; 27(1):60-2. PubMed ID: 3128105
[TBL] [Abstract][Full Text] [Related]
9. 2'-Deoxycoformycin (Pentostatin) in hairy cell leukemia: response in patients refractory to interferon alpha.
Ho AD; Kuse R; Prümmer O; Porzsolt F; Hunstein W
Klin Wochenschr; 1987 Oct; 65(20):975-9. PubMed ID: 3501501
[TBL] [Abstract][Full Text] [Related]
10. Long-term effects of 2'-deoxycoformycin treatment on cytokine production in patients with hairy cell leukemia.
Ho AD; Männel DN; Wulf G; Kirchner H; Gundt A; Trede I; Rensch K; Hunstein W
Leukemia; 1990 Aug; 4(8):584-9. PubMed ID: 1697012
[TBL] [Abstract][Full Text] [Related]
11. Concomitant effect of 2'-deoxycoformycin on natural killer cell activity and tumour cell sensitivity to lysis in hairy cell leukaemia--discordant effects of alpha interferon.
Lahat N; Aghai E; Merchav S; Kinarty A; Sobel E; Froom P
Scand J Immunol; 1990 Aug; 32(2):205-9. PubMed ID: 2389114
[TBL] [Abstract][Full Text] [Related]
12. The treatment of hairy-cell leukaemia with 2'-deoxycoformycin.
Johnston JB; Glazer RI; Pugh L; Israels LG
Br J Haematol; 1986 Jul; 63(3):525-34. PubMed ID: 3488071
[TBL] [Abstract][Full Text] [Related]
13. Deoxycoformycin in therapy of refractory lymphoid neoplasms.
Ho AD; Thaler J; Kuse R; Willemze R; Mandelli F; Lauria F; Zittoun R; Stryckmans P
Onkologie; 1988 Feb; 11(1):35-7. PubMed ID: 3283623
[TBL] [Abstract][Full Text] [Related]
14. Clinical trials in hairy cell leukemia. Current status and future directions.
Cheson BD; Martin A
Ann Intern Med; 1987 Jun; 106(6):871-8. PubMed ID: 3555204
[TBL] [Abstract][Full Text] [Related]
15. Peripheral blood and bone marrow changes following 2'-deoxycoformycin therapy in hairy cell leukemia. Results of 200 weeks' follow-up.
Dalal BI; Freier L; Johnston JB; Merry CC; Israels LG
Cancer; 1989 Jan; 63(1):14-22. PubMed ID: 2783375
[TBL] [Abstract][Full Text] [Related]
16. Treatment of hairy cell leukemia: the Ohio State University experience with deoxycoformycin.
Bouroncle BA; Grever MR; Kraut EH
Leukemia; 1987 Apr; 1(4):350-4. PubMed ID: 3499542
[TBL] [Abstract][Full Text] [Related]
17. The treatment of hairy cell leukemia with 2'-deoxycoformycin: results in India and in the United States.
Spiers AS; Parekh SJ
Leukemia; 1987 Apr; 1(4):347-50. PubMed ID: 3499541
[TBL] [Abstract][Full Text] [Related]
18. Plasma levels of soluble CD8 antigen and interleukin-2 receptor antigen in patients with hairy cell leukemia, relationship with splenectomy and with clinical response to therapy.
Ho AD; Grossmann M; Knauf W; Martin H; Trümper L; Zwingers T; Sonnen R; Pralle H; Hunstein W
Leukemia; 1989 Oct; 3(10):718-23. PubMed ID: 2506398
[TBL] [Abstract][Full Text] [Related]
19. Remissions in hairy-cell leukemia with pentostatin (2'-deoxycoformycin).
Spiers AS; Moore D; Cassileth PA; Harrington DP; Cummings FJ; Neiman RS; Bennett JM; O'Connell MJ
N Engl J Med; 1987 Apr; 316(14):825-30. PubMed ID: 2434850
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of 2'-deoxycoformycin in hairy-cell leukemia: a study of the National Cancer Institute of Canada Clinical Trials Group.
Johnston JB; Eisenhauer E; Corbett WE; Scott JG; Zaentz SD
J Natl Cancer Inst; 1988 Jul; 80(10):765-9. PubMed ID: 3290498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]